Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D M Mann

Showing results (191-200 of 229) with videos related to

Pageof 23
Sort By:
Neuroscience Letters|August 18, 1995
The extent of amyloid deposition in brain in patients with Down's syndrome does not depend upon the apolipoprotein E genotypeD M Mann, S M Pickering-Brown, M A Siddons, et al.
Journal of the Neurological Sciences|September 1, 1989
Immunocytochemical profile of neurofibrillary tangles in Down's syndrome patients of different agesD M Mann, D Prinja, C A Davies, et al.
Brain Research|June 30, 1987
Catecholaminergic neurones assessed ante-mortem in Alzheimer's diseaseA M Palmer, P T Francis, D M Bowen, et al.
Brain Research|April 10, 1989
Reduced D-[3H]aspartate binding in Down's syndrome brainsM D Simpson, P Slater, A J Cross, et al.
Chest|July 23, 1998
Percutaneous pulmonary endoarterial biopsy in an experimental model of pulmonary hypertensionA Rothman, D M Mann, C A Behling, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|February 1, 1986
Cerebral biopsy in the investigation of presenile dementia due to cerebral atrophyD Neary, J S Snowden, D M Bowen, et al.
Brain Research|May 2, 1994
Postmortem brains reveal similar but not identical amyloid precursor protein-like immunoreactivity in Alzheimer compared with other dementiasM T Webster, P T Francis, A W Procter, et al.
Journal of Neuropathology and Experimental Neurology|November 24, 1998
Quantification of modified amyloid beta peptides in Alzheimer disease and Down syndrome brainsR Hosoda, T C Saido, L Otvos, et al.
Neuroscience Letters|January 24, 1997
An intronic polymorphism in the presenilin-1 gene does not influence the amount or molecular form of the amyloid beta protein deposited in Alzheimer's diseaseD M Mann, S M Pickering-Brown, N N Bayatti, et al.
Neuropathology and Applied Neurobiology|October 19, 2017
Inflammatory pathology markers (activated microglia and reactive astrocytes) in early and late onset Alzheimer disease: a post mortem studyR Taipa, V Ferreira, P Brochado, et al.
Pageof 23

Showing results (191-200 of 229) with videos related to

Sort By:
Pageof 23
Neuroscience Letters|August 18, 1995
The extent of amyloid deposition in brain in patients with Down's syndrome does not depend upon the apolipoprotein E genotypeD M Mann, S M Pickering-Brown, M A Siddons, et al.
Journal of the Neurological Sciences|September 1, 1989
Immunocytochemical profile of neurofibrillary tangles in Down's syndrome patients of different agesD M Mann, D Prinja, C A Davies, et al.
Brain Research|June 30, 1987
Catecholaminergic neurones assessed ante-mortem in Alzheimer's diseaseA M Palmer, P T Francis, D M Bowen, et al.
Brain Research|April 10, 1989
Reduced D-[3H]aspartate binding in Down's syndrome brainsM D Simpson, P Slater, A J Cross, et al.
Chest|July 23, 1998
Percutaneous pulmonary endoarterial biopsy in an experimental model of pulmonary hypertensionA Rothman, D M Mann, C A Behling, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|February 1, 1986
Cerebral biopsy in the investigation of presenile dementia due to cerebral atrophyD Neary, J S Snowden, D M Bowen, et al.
Brain Research|May 2, 1994
Postmortem brains reveal similar but not identical amyloid precursor protein-like immunoreactivity in Alzheimer compared with other dementiasM T Webster, P T Francis, A W Procter, et al.
Journal of Neuropathology and Experimental Neurology|November 24, 1998
Quantification of modified amyloid beta peptides in Alzheimer disease and Down syndrome brainsR Hosoda, T C Saido, L Otvos, et al.
Neuroscience Letters|January 24, 1997
An intronic polymorphism in the presenilin-1 gene does not influence the amount or molecular form of the amyloid beta protein deposited in Alzheimer's diseaseD M Mann, S M Pickering-Brown, N N Bayatti, et al.
Neuropathology and Applied Neurobiology|October 19, 2017
Inflammatory pathology markers (activated microglia and reactive astrocytes) in early and late onset Alzheimer disease: a post mortem studyR Taipa, V Ferreira, P Brochado, et al.
Pageof 23